Member Info for Kingalf

That's 0.0085p

I'd wait, I can see these as low as 0.85p

Maybe it's just me, but I wasn't never of the opinion that OBD would be able to scale this up and become a mass producer, they are not set up for that. My hope was that a third party would come in and deal with all the mass marketing ect.

I think it's great news that they announced

Surly this statement is what will push these higher

"Confidential discussions commenced with third parties regarding monetizing OBD's two most advanced pipeline assets"

They are in talks with more than one interested party It's exactly what we need but clearly the market is focusing on in my eyes irrelevant sales figures. Eagerly awaiting news regarding a bid or possibly 2

Irrelevant Vaiter, read my post from earlier. They'll have all the cash they need and some

Surly this statement is what will push these higher

Confidential discussions commenced with third parties regarding monetizing OBD's two most advanced pipeline assets: EpiSwitch® NST (No Stool Test) for colorectal/bowel cancer and EpiSwitch® SCB (Specific for Canine Blood) blood test for detection of multiple types of canine cancer

Very strange RNS, is Huw trying to give the impression that now Stalicla have raised all this money, Evgen could be inline for a payout ???

Is this what him and Toni were referring to when they said that they were working on adding to shareholder value, creating false impression that will lead to a speculative frenzy so as to suck in more unsuspecting punters.

The whole communication is poorly written and leaves more questions than answers. One certainty is that it adds more weight to the argument that he is out of his depth and a complete amateur.

CJ39 - I could be completely wrong but I don't think they were ever at £1.50, I seem to recall them originally being issued at around 35p.

Funny how Proinvester has gone away, might have decided that his ramping wasn't working and has sold out.

I do think existing shareholders should start to consider ousting Huw during the next AGM. He has proved to be completely out of his depth, blatantly lying and ramping up the share price just before a share placement announcement.

Funny how some on here view Toni as some kind of saviour, I personally think he is just another drain on a shrinking reserve. The company has way to many directors who all hold second or third jobs being paid a full time salary it's scandalous.

Why is Huw still at the helm, having presided over a 90% share decline he is somewhat fortunate to still have a job, in any other job with proper checks and balances he would have been long gone.

In fairness to CJ39 and where you are slightly bending the information out there to your own angle

"Did Evgen receive ‘up to $6m’ in 2023? Yes, Evgen received $500k from Stalicla"

The 500k wasn't part of that $6m and that was made perfectly clear in the RNS.

It's nice to see a slight pick up in the price, the cynic in me thinks the MM have a massive overhang in stock from the AXA sale and are artificially trying to generate a false dawn to attract more buyers, or it could just be part of a re rating of the whole sector.

Pro I would like your thoughts on when you think Evgen will undertake a new placement and how much they are likely to raise.

Going by the last cash call, they raised funds around 9 months prior to when the cash was due to run out, it would be somewhat suicidal not to bother at all in the hope that Stalicla come through.

They could always borrow the money I suppose which would protect shareholders value but at what cost.

We are all pretty much in agreement that if Stalicla doesn't come through with the funds a cash call is inevitable, Pro how much do you think they'll have to raise in such a scenario, £10m was the last call.

One thing is for certain and why my trust in the bods is so low, prior to any announcement there will be a flurry of positive news promising the earth to ramp the price up.

Huw was in overdrive with positive announcements just prior to the last cash call, that together with his track record when it comes to failed companies doesn't feel me with confidence and why I'm so passionate about making sure that other non suspecting punters don't fall into the same trap.

Until Toni dips their hand in their pocket and buys your enthusiasm seems misplaced. As far as I'm concerned it's more bees round the honey pot depleting the dwindling reserves.

Well let's work on the facts we have today and assume Stalicla doesn't come through with any cash which is a very real possibility. How much would you expect them to have to raise under those circumstances ?

I used £10 million as an example because that is what they previously did.

The Bods have completely messed this up by allowing the SP to drop so much, these types of companies need a steady stream of funds to survive, but it gets to a point which in my opinion we've gone well past that shareholder value is irreplaceabley damaged and nothing can be salvaged even if the product proves to be successful. They'll be to many shares in issue to be worth anything to existing holders. Give it a year or so and these will be trading at fraction of a pence.

I personally think Huw is not far away from a career suicide, have you seen how many companies have gone into administration under his stewardship.

The company has stated that they will run out of cash by quarter 4, given the choice as to whether to dilute the shares by such a large margin or go into administration due to lack of funds most shareholders would seek the dilution options.

Everything seems to be riding on this Stalicla payment, which to me sounds just like the super Juv deal that never happened.

Talk it up as much as you like, you've got plenty of die hards on here more than happy to lap up your ramping. The reality is that they are running out of cash and a massive share dilution is the only thing that will keep the company afloat

If they try and raise £10 million again at today's price they'll have to issue around 666 million shares, add that to the current issue of 275 million they'll have a hefty 941 million shares in issue. If these ever got back to 10p, it would value the company at £94 million. Can you now see why any share dilution is a complete disaster for existing holders and why the bods are reluctant to buy.

AXA probably got wind of a new placement, they are either getting out all together as the dilution at these levels will probably wipe out any potential future share price growth, or alternatively are freeing up cash to participate at a much lower placement price. I personally think they are cutting their losses.

There is absolutely no reason to ramp this up as it's pipeline speaks for itself. The Bods are also heavily invested.

Oxford Biodynamics - OBD is the one to look at, imho it will be the best trading share of 2024

Broom, just to add a little context, staff could subscribe to £3600 worth of shares at 1.12, that would equate to approximately £7200 at today's market price. Admittedly not everyone has sold at the first opportunity but the ones that have would have had an impact as demonstrated by the share price movement compared to both Lloyds and Barclays

Contrary to all the posts this morning, the reason for the sell of is that staff 3 year share options matured with a strike price of £1.124 pence. The selling is down to staff taking their near 100% return. And before some smart ar-s suggests they know something hence the selling, it's purely down to the average employee isn't paid much and historically it's a decent return

Like the majority of AIM shares they need a constant supply of fuel in this case news to keep the share price fire raging. It's definitely smouldering at the moment and some may even think it's gone out, but as anyone who has had a bonfire knows, add a little combustible material and this will be raging again.

It should give us all a great deal of confidence that the bods are so heavily invested. So many AIM companies where the bods talk a good book but have zero skin in the game, Evgen is a prime example